Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Title: subject Index To Volume 2
Volume: 3 Issue: 1
Author(s): Bentham Science Publishers
Affiliation:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , subject Index To Volume 2, Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents 2003; 3 (1) . https://dx.doi.org/10.2174/1568013033358725
DOI https://dx.doi.org/10.2174/1568013033358725 |
Print ISSN 1568-0134 |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-0134 |
Related Books
10
Related Articles
-
Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review
Current Pharmaceutical Design Matrix Metalloproteinases: A Therapeutic Target in Cardiovascular Disease
Current Pharmaceutical Design A Brief Evaluation of Tumor Imaging in Mice with 99mTc-glucarate Including a Comparison with 18F-FDG
Current Radiopharmaceuticals Tritiated Opioid Receptor Ligands as Radiotracers
Current Pharmaceutical Design Adenoviral Vector Immunity: Its Implications and Circumvention Strategies
Current Gene Therapy From French Paradox to Cancer Treatment: Anti-cancer Activities and Mechanisms of Resveratrol
Anti-Cancer Agents in Medicinal Chemistry On the Nature of the Tumor-Initiating Cell
Current Stem Cell Research & Therapy Glioblastoma Multiforme Formation and EMT: Role of FoxM1 Transcription Factor
Current Pharmaceutical Design An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
Anti-Cancer Agents in Medicinal Chemistry Class II Phosphoinositide 3-Kinases as Potential Novel Drug Targets
Current Signal Transduction Therapy The Impact of DIDS-Induced Inhibition of Voltage-Dependent Anion Channels (VDAC) on Cellular Response of Lymphoblastoid Cells to Ionizing Radiation
Medicinal Chemistry EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?
Current Genomics Overview of Brain Tumor Stem Cells – Implications for Treatment
Current Signal Transduction Therapy Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy
Current Cancer Drug Targets Preface
Current Pharmaceutical Design Immuno-Isolation in Cancer Gene Therapy
Current Gene Therapy Heme Oxygenase -1 Gene Therapy: Recent Advances and Therapeutic Applications
Current Gene Therapy Advances in Nanocarriers for Anticancer Drugs Delivery
Current Medicinal Chemistry mTOR Inhibitors: Facing New Challenges Ahead
Current Medicinal Chemistry PET and SPECT Imaging for the Acceleration of Anti-Cancer Drug Development
Current Drug Targets